Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R; EUROCARE-6 Working Group.
Sant M, et al. Among authors: mousavi sm.
Lancet Oncol. 2024 May 1:S1470-2045(24)00141-4. doi: 10.1016/S1470-2045(24)00141-4. Online ahead of print.
Lancet Oncol. 2024.
PMID: 38703784